Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.

Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L, Stine SH, Coleman RE.

J Clin Oncol. 2008 May 1;26(13):2155-61. doi: 10.1200/JCO.2007.14.5631. Epub 2008 Mar 24. Erratum in: J Clin Oncol. 2008 Sep 1;26(25): 4229.

PMID:
18362365
2.

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

Facey K, Bradbury I, Laking G, Payne E.

Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. Review.

3.

Medicare coverage of PET for cervical cancer.

Carey BP, Coleman RE, Grigsby PW, Siegel BA.

J Am Coll Radiol. 2006 Jan;3(1):19-22. Review.

PMID:
17412001
4.

Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.

Oldan JD, Patel PS.

Obstet Gynecol Surv. 2016 Sep;71(9):545-56. doi: 10.1097/OGX.0000000000000345. Review.

PMID:
27640609
5.

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.

Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyögg J.

J Nucl Med Technol. 2010 Mar;38(1):6-17. doi: 10.2967/jnmt.108.059584. Review.

6.

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.

Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyögg J.

J Nucl Med. 2010 Mar;51(3):401-12. doi: 10.2967/jnumed.108.059584. Epub 2010 Feb 11. Review.

7.

Positron emission tomography: current status and future challenges.

Lin M, Shon IH, Lin P.

Intern Med J. 2010 Jan;40(1):19-29. doi: 10.1111/j.1445-5994.2009.02072.x. Review.

PMID:
20561362
8.

Clinical PET/CT imaging: promises and misconceptions.

Czernin J, Auerbach MA.

Nuklearmedizin. 2005;44 Suppl 1:S18-23. Review.

PMID:
16395974
9.

PET in pediatric diseases.

Jadvar H, Alavi A, Mavi A, Shulkin BL.

Radiol Clin North Am. 2005 Jan;43(1):135-52. Review.

PMID:
15693653
10.

[PET contribution in oncology].

Zimmermann M, Lüthi F, Zouhair A, Ketterer N, Prior JO, Kamel ME, Bischof-Delaloye A.

Rev Med Suisse. 2005 May 18;1(20):1335-8, 1341-2. Review. French.

PMID:
15991625
11.

Imaging and oncologic drug development.

El-Deiry WS, Sigman CC, Kelloff GJ.

J Clin Oncol. 2006 Jul 10;24(20):3261-73. Review.

PMID:
16829650
12.

PET imaging of cancer immunotherapy.

Tumeh PC, Radu CG, Ribas A.

J Nucl Med. 2008 Jun;49(6):865-8. doi: 10.2967/jnumed.108.051342. Review.

13.

Positron Emission Testing for Six Cancers (Brain, Cervical, Small Cell Lung, Ovarian, Pancreatic And Testicular) [Internet].

Matchar DB, Kulasingam SL, Havrilesky L, Mann LO, Myers ER, McCrory DC, Patwardhan M, Prosnitz R.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Feb 12.

14.

Use of Positron Emission Tomography and Other Neuroimaging Techniques in the Diagnosis and Management of Alzheimer’s Disease and Dementia [Internet].

Matchar DB, Kulasingam SL, McCrory DC, Patwardhan MB, Rutschmann OT, Samsa GP, Schmechel DE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2001 Dec 14.

15.

Biological imaging for selecting and monitoring cancer therapy; a pathway to individualised therapy.

Schwaiger M, Peschel C.

Eur J Nucl Med Mol Imaging. 2006 Jul;33 Suppl 1:1-5. Review. No abstract available.

PMID:
16703366

Supplemental Content

Support Center